2010
DOI: 10.3899/jrheum.100180
|View full text |Cite
|
Sign up to set email alerts
|

Levels of Transforming Growth Factor-β Are Low in Systemic Lupus Erythematosus Patients with Active Disease

Abstract: Lower TGF-β1 was the most consistent cytokine abnormality in patients with SLE. The associations with disease activity, lymphocyte subsets, and damage suggest that TGF-β1 may be a therapeutic target of interest in SLE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
60
0
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 82 publications
(69 citation statements)
references
References 54 publications
(58 reference statements)
7
60
0
2
Order By: Relevance
“…Consumption in the kidney may reflect lower circulating levels of TGF␤1, which seem to be associated with severe disease, kidney involvement, and worse outcome in SLE (35,36). Additionally, an elevated total plasma level of TGF␤1 in SLE has been shown in some studies, and TGF␤1-transgenic mice develop a glomerulonephritis resembling immune complex-mediated glomerular injury (22).…”
Section: Discussionmentioning
confidence: 99%
“…Consumption in the kidney may reflect lower circulating levels of TGF␤1, which seem to be associated with severe disease, kidney involvement, and worse outcome in SLE (35,36). Additionally, an elevated total plasma level of TGF␤1 in SLE has been shown in some studies, and TGF␤1-transgenic mice develop a glomerulonephritis resembling immune complex-mediated glomerular injury (22).…”
Section: Discussionmentioning
confidence: 99%
“…Although serum TGF-ß levels reflect the total production from many cellular sources, Becker-Merok, et al have demonstrated that decreased TGF-ß production correlated with decreased CD4+, CD8+, and NK cell frequency, implicating the reduction of these cell subsets as responsible for the decreased level of this cytokine 3 . Recent studies have also revealed that CD4+CD25+Foxp3+ regulatory/suppressor (Treg) cells may be another important source for the TGF-ß expression and/or production.…”
Section: Transforming Growth Factor-ß Level: Indicator For Severity Omentioning
confidence: 99%
“…However, in their study in this issue of The Journal, Becker-Merok, et al provide new evidence that lower serum TGF-ß1 levels may be the most consistent cytokine abnormality in SLE. They found that a lower TGF-ß1 level correlates with disease activity, a reduction in CD4+, CD8+ and NK cell numbers, and severe organ damage in active SLE 3 . The authors also demonstrated that decreased TGF-ß1 level seems to be an intrinsic defect, since corticosteroid treatment did not interfere with its production in patients with active SLE.…”
Section: Transforming Growth Factor-ß Level: Indicator For Severity Omentioning
confidence: 99%
“…Circulating levels of IL-1b were elevated in Sjögren's syndrome (15), but not in autoimmune hemolytic anemia (16). Reported levels of IL-1b in systemic lupus erythematosus (SLE) patient serum range from undetected (17,18), decreased in SLE relative to controls (19,20), to increased in a small percentage of patients (21). IL-1b levels may be higher in subsets of patients such as those with neuropsychiatric SLE (22) or vascular damage (20).…”
mentioning
confidence: 99%
“…Reported levels of IL-1b in systemic lupus erythematosus (SLE) patient serum range from undetected (17,18), decreased in SLE relative to controls (19,20), to increased in a small percentage of patients (21). IL-1b levels may be higher in subsets of patients such as those with neuropsychiatric SLE (22) or vascular damage (20). The other cytokine produced by the inflammasome, IL-18, is elevated in the serum and glomeruli of SLE patients with lupus nephritis and is associated with localization of plasmacytoid dendritic cells to glomeruli (23,24).…”
mentioning
confidence: 99%